Pane-Pianese C, De la Llata SC, Tella VC, Hernaiz LJ, Pane NM

Language: Spanish
References: 14
Page: 1-14
PDF size: 357.55 Kb.

ABSTRACT

Background: Vestibular migraine is a common cause of equilibrium disorders that is characterized by vertigo attacks and disequilibrium that may last minutes up to days, it’s associated with migraines headaches or prodromic symptoms of migraine. Due to the variability in symptoms of vestibular patients, follow up can be difficult. The Dizziness Handicap Inventory (DHI) is a standardized system for vestibular symptomatology with high accuracy and reliability used in this context.
Objective: To describe the characteristics of patients diagnosed with vestibular migraine and the results of the Dizziness Handicap Inventory before and after treatment.
Materials and Methods: A descriptive study including patients diagnosed with vestibular migraine from March 2018 to March 2020. Patients answered Dizziness Handicap Inventory questionnaires during their initial appointments and after a new treatment or treatment adjustments.
Results: There were included 28 patients, age ranged between 10 to 69 years, and 78% of patients were female. The most frequent symptoms were headache (64.3%), dizziness (57.1%) and tinnitus (42.8%). Specific treatments varied by patients, but most of them received topiramate (37.9%), ergotamine (17.2%) and acetylsalicylic acid 17.2%). Total Dizziness Handicap Inventory scores significantly decreased (p ≥ 0.0001) after treatment.
Conclusions: Most patients diagnosed with vestibular migraine improve their Dizziness Handicap Inventory scores after treatment, regardless of the specific medications prescribed.

REFERENCES

1. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): Vestibular migraine? J Neurol 1999; 246 (10): 883-892. doi. 10.1007/s004150050478.

2. Hood JD, Square Q. Neuro-otological manifestations. Am J Otol. Published online 1984: 1123-1142.

3. Neuhauser H, Leopold M, Von Brevern M, Arnold G, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurol 2001; 56 (4): 436-441. doi. 10.1212/WNL.56.4.436.

4. Vuković V, Plavec D, Galinović I, Lovrenčić-Huzjan A, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache 2007; 47 (10): 1427- 1435. doi. 10.1111/j.1526-4610.2007.00939.x.

5. Reploeg MD, Goebel JA. Migraine-associated dizziness: Patient characteristics and management options. Otol Neurotol 2002; 23 (3): 364-371. doi. 10.1097/00129492-200205000-00024.

6. Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol 2016; 263 (1): 82-89. doi. 10.1007/s00415-015-7905-2.

7. Committee C, Society B, Publications I. Bárány Society initiative for the establishment of the International Classification of Vestibular Disorders (ICVD).

8. Lempert T, Olesen J, Furman J, Waterston J, et al. Vestibular migraine: Diagnostic criteria. J Vestib Res Equilib Orientat 2012; 22 (4): 167-172. doi. 10.3233/VES-2012-0453.

9. Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia 2018; 38 (1): 1-211. doi. 10.1177/0333102417738202.

10. Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: A population-based survey study. Otol Neurotol 2018; 39 (8): 1037-1044. doi. 10.1097/ MAO.0000000000001900.

11. Lempert T, Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine. J Neurol 2009; 256 (3): 333-338. doi. 10.1007/s00415-009-0149-2.

12. Wood AJJ. Migraine - Current understanding and treatment. N Engl J Med 2002; 346 (4): 257-270. doi. 10.1056/NEJMra010917.

13. Shin JH, Kim YK, Kim HJ, Kim JS. Altered brain metabolism in vestibular migraine: Comparison of interictal and ictal findings. Cephalalgia 2014; 34 (1): 58-67. doi. 10.1177/0333102413498940.

14. Emiliano MDS, Sabrina MF, Alexander MS. Actualización: Migraña vestibular. Rev Faso. 2015; 75-81.